Skip to content
Home/Companies/Pharma/KD Pharma
KD Pharma

KD Pharma

Pharma·Germany·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns KD Pharma?

KD Pharma is currently owned by capiton through capiton Omega (2019 vintage), since 2019.

Hand-verified · updated 2026-07-03

capiton
Most recent investor
capiton
capiton Omega · 2019 · Buyout
2 ownership periods · full history below

Key facts

HQGermany
SectorPharma
StatusActive
Websitekdpharmagroup.com

Ownership history

2 ownership periods

Active
Currently held by capiton since 2019.
capiton
capitonExited 2019
2013 · 2019(6yr) · capiton IV · 2010 · Buyout
Continuation Vehicle · to
MOIC
–
capiton
capitonActive
2019 · present(7yr) · capiton Omega · 2019 · Buyout

More capiton portfolio companies

From the same investor, across funds.

SAPV Care
Active
HealthcareGermany· 2026
Dec Group
Dec Group
Active
PharmaSwitzerland· 2025
AEMtec
Exited 2026
IndustrialsGermany· 2023
to
Raith
Active
IndustrialsGermany· 2023
Asyril
Asyril
Active
IndustrialsSwitzerland· 2022
GRITEC
Gritec
Exited 2024
ConstructionGermany· 2022
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track KD Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy KD Pharma?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on KD Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue